Cholinergic Neurotransmission and Acetylcholine Physiology

Cholinergic neurotransmission uses acetylcholine as its chemical messenger and is central to the autonomic nervous system. Acetylcholine is the transmitter at all autonomic ganglia (preganglionic to postganglionic, both divisions), at parasympathetic neuroeffector junctions, and at the sympathetic supply to sweat glands. It acts on two broad receptor classes, nicotinic and muscarinic, which give it a wide range of fast and slow effects throughout the viscera.

Definition

Cholinergic neurotransmission is the process by which acetylcholine is synthesized, released, and acts on nicotinic and muscarinic receptors to mediate autonomic ganglionic transmission and parasympathetic (and selected sympathetic) effector responses, with transmission terminated by hydrolysis through acetylcholinesterase.

Scope

This topic covers the synthesis, release, receptor action, and rapid termination of acetylcholine in the autonomic nervous system: where cholinergic transmission occurs, the distinction between nicotinic (ionotropic) and muscarinic (metabotropic) receptors, the signalling pathways they engage, and the role of acetylcholinesterase in ending transmission. It is reference physiology, not clinical guidance.

Core questions

• Where in the autonomic nervous system is acetylcholine the transmitter?
• How do nicotinic and muscarinic receptors differ in mechanism and speed?
• How is acetylcholine synthesized and released, and how is it inactivated?
• How does muscarinic signalling produce its diverse effects on the heart, glands, and smooth muscle?

Key concepts

• Acetylcholine synthesis (choline acetyltransferase) and reuptake of choline
• Nicotinic acetylcholine receptors (ligand-gated ion channels)
• Muscarinic acetylcholine receptors (G-protein-coupled)
• Ganglionic (nicotinic) transmission in both divisions
• Parasympathetic neuroeffector (muscarinic) transmission
• Cholinergic sympathetic innervation of sweat glands
• Acetylcholinesterase and rapid hydrolysis
• Vagal control of the heart and viscera

Key theories

Chemical (humoral) transmission

Loewi's classic experiment showed that stimulating the vagus released a diffusible substance ('Vagusstoff', later identified as acetylcholine) that could slow a second heart, providing decisive evidence that nerves communicate with effectors through chemical messengers rather than purely electrical means.

Mechanisms

Acetylcholine is synthesized in the nerve terminal from choline and acetyl-CoA by choline acetyltransferase, stored in vesicles, and released on depolarization. It acts on two receptor families. Nicotinic receptors are ligand-gated cation channels that mediate fast excitatory transmission, including transmission across autonomic ganglia in both the sympathetic and parasympathetic divisions. Muscarinic receptors are G-protein-coupled and mediate the slower parasympathetic effects on the heart, glands, and smooth muscle; for example, M2 receptors in the heart couple to Gi to slow rate, while other muscarinic subtypes couple to Gq to stimulate secretion or smooth-muscle contraction. The classic demonstration that vagal stimulation releases a chemical transmitter that slows the heart established this humoral mechanism (Loewi, 1921). Transmission is terminated very rapidly by acetylcholinesterase, which hydrolyses acetylcholine in the synaptic cleft, and the resulting choline is taken back up for resynthesis (Kandel et al., 2021; Boron & Boulpaep, 2017). The vagus nerve, the body's major parasympathetic outflow, also participates in neuro-immune signalling (Bonaz et al., 2016).

Clinical relevance

Cholinergic physiology underlies vagal control of heart rate, glandular secretion, and gastrointestinal and bladder motility, and provides the conceptual basis for understanding many autonomic drugs and toxins that act on cholinergic transmission. This entry is descriptive physiology and not a basis for individual treatment decisions.

Evidence & guidelines

The mechanisms described here rest on Loewi's foundational demonstration of chemical transmission (Loewi, 1921) and on standard physiology and neuroscience texts (Kandel et al., 2021; Boron & Boulpaep, 2017), with vagal neuro-immune roles reviewed by Bonaz et al. (2016). It is reference physiology rather than the subject of clinical guidelines.

History

Otto Loewi's 1921 frog-heart experiment provided the first direct evidence of chemical neurotransmission, showing that vagal stimulation released a substance that slowed a second heart; this substance was subsequently identified as acetylcholine (Loewi, 1921). Henry Dale's work distinguished the nicotinic and muscarinic actions of acetylcholine and clarified its role as the transmitter at autonomic ganglia and parasympathetic endings, establishing the chemical framework still used today.

Key figures

• Otto Loewi
• Henry Hallett Dale
• John Newport Langley

Seminal works

• loewi-1921

Frequently asked questions

What is the difference between nicotinic and muscarinic receptors?

Nicotinic receptors are ligand-gated ion channels that mediate fast transmission, including across autonomic ganglia, whereas muscarinic receptors are G-protein-coupled receptors that mediate slower parasympathetic effects on the heart, glands, and smooth muscle.

Why does acetylcholine act so briefly?

Because the enzyme acetylcholinesterase hydrolyses acetylcholine in the synaptic cleft very rapidly, terminating its action almost as soon as it is released and recycling choline for resynthesis.